HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis.

导出 LinkOut

翻译打印收藏纠错

作者： Elvira,Favoino ^[1] ; Livio,Urso ^[1] ; Alessandra,Serafino ^[1] ; Francesca,Misceo ^[1] ; Giacomo,Catacchio ^[1] ; Marcella,Prete ^[1] ; Federico,Perosa ^[1]

作者单位： Department of Biomedical Science and Human Oncology (DIMO), Rheumatic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Piazza G. Cesare 11, I-70124 Bari, Italy. ^[1]

关键词 ASAS classification criteria clinical management human leukocyte antigen spondyloarthritis undifferentiated enthesitis and/or arthritis

DOI 10.3390/jcm10143006

PMID 34300172

发布时间 2021-07-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of clinical medicine

2021年10卷14期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

HLA Allele Prevalence in Disease-Modifying Antirheumatic Drugs-Responsive Enthesitis and/or Arthritis Not Fulfilling ASAS Criteria: Comparison with Psoriatic and Undifferentiated Spondyloarthritis.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除